Skip navigation
All CNBC  |  News  |  Video


Company: ISIS Pharmaceuticals Inc
ISIS Pharmaceuticals Inc : [ISIS  Loading...      ()   ]
VIDEO | COMPANIES : ISIS Pharmaceuticals Inc
Protection of intellectual property rights in China has improved in the last few years, says Steve Yang, vice president ...
Insight on why regional banks could be major players in the market, with Peyton Patterson, NewAlliance Bancshares, Inc. ...
A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Me...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Diabetes is a global epidemic that presents an estimated $25 billion drug and device market and some predict that number...
News |  COMPANY : ISIS Pharmaceuticals
Tuesday, 17 Nov 2009
Source: Reuters


Current DateTime: 01:04:17 24 Nov 2009
LinksList Documentid: 23188555



Current DateTime: 01:01:12 24 Nov 2009
LinksList Documentid: 23188557

Current DateTime: 01:19:41 24 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:04:16 24 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:09:39 24 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:04:16 24 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters